日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prognostic Value of Circulating Tumor Cells and Cancer Associated Macrophage-Like Cells in Metastatic Non-Small Cell Lung Cancer Patients: A Retrospective Exploratory Analysis

循环肿瘤细胞和癌相关巨噬细胞样细胞在转移性非小细胞肺癌患者中的预后价值:一项回顾性探索性分析

Siringo, Marco; Meo, Michela De; Gelibter, Alain Jonathan; Nicolazzo, Chiara; Gazzaniga, Paola

BRCA Screening and Identification of a Common Haplotype in the Jewish Community of Rome Reveal a Founder Effect for the c.7007G>C, p. (Arg2336Pro) BRCA2 Variant

BRCA筛查和罗马犹太社区常见单倍型的鉴定揭示了c.7007G>C,p.(Arg2336Pro) BRCA2变异的创始人效应

De Marchis, Laura; Gelibter, Alain Jonathan; Mammone, Giulia; Madaio, Raffaele Angelo; Aretini, Paolo; De Bonis, Maria; Zampatti, Stefania; Peconi, Cristina; Guadagnolo, Daniele; Vestri, Annarita; Pizzuti, Antonio; Giardina, Emiliano; Capoluongo, Ettore Domenico; Minucci, Angelo

Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients-A Retrospective Observational Study

根据体重指数评估ALK抑制剂在ALK重排非小细胞肺癌患者中的疗效——一项回顾性观察研究

Siringo, Marco; Gentile, Gabriella; Caponnetto, Salvatore; Sperduti, Isabella; Santini, Daniele; Cortesi, Enrico; Gelibter, Alain Jonathan

Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?

肾细胞癌联合治疗:是每位患者的最佳选择吗?

Rossi, Ernesto; Bersanelli, Melissa; Gelibter, Alain Jonathan; Borsellino, Nicolò; Caserta, Claudia; Doni, Laura; Maruzzo, Marco; Mosca, Alessandra; Pisano, Carmela; Verzoni, Elena; Zucali, Paolo Andrea

Evaluation of Drug-Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors

EGFR突变型非小细胞肺癌患者接受酪氨酸激酶抑制剂治疗期间药物相互作用的评估

Occhipinti, Mario; Brambilla, Marta; Galli, Giulia; Manglaviti, Sara; Giammaruco, Maristella; Prelaj, Arsela; Ferrara, Roberto; De Toma, Alessandro; Proto, Claudia; Beninato, Teresa; Zattarin, Emma; Lo Russo, Giuseppe; Gelibter, Alain Jonathan; Simmaco, Maurizio; Preissner, Robert; Garassino, Marina Chiara; De Braud, Filippo; Marchetti, Paolo